Pulished Date August, 2019
ID: 3323
Share on
Share on

Middle East & Africa Metabolomics Market Research Report - Segmented By Product, Indication, Application & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecast To 2024

Pulished: August, 2019
ID: 3323
Pages: 175

Middle East & Africa Metabolomics Market Size & Growth (2019-2024):

The Middle East & Africa Metabolomics Market Size is valued at USD 210 Million in 2019 and estimated to grow at a CAGR of 25%, to reach USD 630 Million by 2024 during the forecast period 2019-2024.

Metabolomics is the significant scale research of little molecules, generally known as metabolites, inside cells, biofluids, tissues or living beings. Metabolomics is a proficient approach since metabolites and their concentration not like other "omics" measures, straightforwardly reflect the unseen biochemical movement and condition of tissues. Consequently, metabolomics signifies to the atomic phenotype. Aggregately, these little atoms and their associations inside an organic framework are known as the metabolome.

The emerging recognition of metabolomics in customized medicines is one of the key factors boosting the growth of the market. The expanding biotech innovative work and pharmaceutical consumption are prompting persistent headways in innovation, spelling development for the worldwide metabolomics market. The unexplored markets in rising countries will goad new development open doors for market players. Further, the requirement for precisely qualified specialists and the lack of the same is limiting the expansion of the metabolomics market. The Middle East and Africa Metabolomics market are evolving at a remarkably quick speed.

This research report on the Middle East & Africa Metabolomics Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

  • By Product: GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface-based mass analysis
  • By Indication: Oncology, Cardiology, Inborn Error.
  • By Application: Nutrigenomics, Toxicology, Biomarker & Drug Discovery
  • By Country: KSA, UAE, Israel, the rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA.

On the Basis of Application, the Biomarker Discovery segment had the largest share in 2018 in the global metabolomics market. Efficiency and reliability has been cited as the reason for the growth of biomarkers. However collaboration between biotechnology and pharmaceutical companies, the personalized medical segment is expected to have the highest CAGR.

On the basis of region, the Middle East and Africa have an untapped market and key players are slowly expanding to this region which is the main reason for the growth of the market in this region.

Key Companies leading the Middle East & Africa Metabolomics Market Profiled in the Report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.) are the leaders in the North America Metabolomics market.


                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Metabolomic Instruments                               


                                                       Gas Chromatography (GC)

                                                       Capillary Electrophoresis (CE)

                                                       High-performance Liquid Chromatography (HPLC)

                                                       Ultra-performance Liquid Chromatography (UPLC)

                                       Detection Tools 

                                                       Mass Spectrometry

                                                       Nuclear Magnetic Resonance Spectroscopy

                                                       Surface-Based Mass Analysis

                                5.1.2 Metabolomics Bioinformatics Tools and Services                   

                                       Bioinformatics Tools & Databases              

                                       Bioinformatics Services  

                                5.1.3 Y-o-Y Growth Analysis, By Product                               

                                5.1.4 Market Attractiveness Analysis, By Product                             

                                5.1.5 Market Share Analysis, By Product                               

                5.2 Indication                                    

                                5.2.1 Cancer                      

                                5.2.2 Cardiovascular Disorders                   

                                5.2.3 Inborn errors                         

                                5.2.4 Neurological Errors                              

                                5.2.5 Other Indications                 

                                5.2.4 Y-o-Y Growth Analysis, By Indication                           

                                5.2.5 Market Attractiveness Analysis, By Indication                         

                                5.2.6 Market Share Analysis, By Indication                           

                5.3 Application                                 

                                5.3.1 Nutrigenomics                       

                                5.3.2 Toxicology                               

                                5.3.3 Biomarker & Drug Discovery                            

                                5.3.4 Functional Genomics                          

                                5.3.5 Personalized Medicine                      

                                5.3.6 Other Applications

                                5.3.7 Y-o-Y Growth Analysis, By Application                         

                                5.3.8 Market Attractiveness Analysis, By Application                       

                                5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                                6.1.4 Market Attractiveness Analysis                      

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                                6.1.5 Market Share Analysis                       

                                       By Geographical Area     

                                       By Product           

                                       By Indication       

                6.2 Middle-East                                                

                6.3 Africa                                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Waters Corporation (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Human Metabolome Technologies, Inc. (Japan)                                        

                8.4 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.5 LECO Corporation (U.S.)                                        

                8.6 Bruker Corporation (U.S.)                                    

                8.7 Shimadzu Corporation (Japan)                                           

                8.8 Metabolon Inc. (U.S.)                                            

                8.9 Danaher Corporation (U.S.)                                 

                8.10 Biocrates Life Sciences AG (Austria)                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          


                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Metabolomics Market By Product, From 2019-2024 ( USD Million )
  2. Middle East & Africa GC Market By Region, From 2019-2024 ( USD Million )
  3. Middle East & Africa Bioinformatics Market By Region, From 2019-2024 ( USD Million )
  4. Middle East & Africa Mass Spectroscopy Market By Region, From 2019-2024 ( USD Million )
  5. Middle East & Africa HPLC Market By Region, From 2019-2024 ( USD Million )
  6. Middle East & Africa UPLC Market By Region, From 2019-2024 ( USD Million )
  7. Middle East & Africa NMRS Market By Region, From 2019-2024 ( USD Million )
  8. Middle East & Africa Surface Based analysis Market By Region, From 2019-2024 ( USD Million )
  9. Middle East & Africa Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  10. Middle East & Africa Oncology Market By Region, From 2019-2024 ( USD Million )
  11. Middle East & Africa Cardiology Market By Region, From 2019-2024 ( USD Million )
  12. Middle East & Africa Inborn Errors Market By Region, From 2019-2024 ( USD Million )
  13. Middle East & Africa Metabolomics Market By Application, From 2019-2024 ( USD Million )
  14. Middle East & Africa Nutrigenomics Market By Region, From 2019-2024 ( USD Million )
  15. Middle East & Africa Toxicology Market By Region, From 2019-2024 ( USD Million )
  16. Middle East & Africa Biomarker & Drug Discovery Market By Region, From 2019-2024 ( USD Million )
  17. Middle East Metabolomics Market By Product, From 2019-2024 ( USD Million )
  18. Middle East Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  19. Middle East Metabolomics Market By Application, From 2019-2024 ( USD Million )
  20. Africa Metabolomics Market By Product, From 2019-2024 ( USD Million )
  21. Africa Metabolomics Market By Indication, From 2019-2024 ( USD Million )
  22. Africa Metabolomics Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample